CYCLOSPORINE-A AND ITS HOMOLOGS, CYCLOSPORINE-G AND CYCLOSPORINE-H DIRECTLY INHIBIT NORMAL AND ICHTHYOTIC KERATINOCYTE GROWTH IN CULTURE

被引：0

作者：

AMSELLEM, C ^{[1
]}

HAFTEK, M ^{[1
]}

KANITAKIS, J ^{[1
]}

THIVOLET, J ^{[1
]}

机构：

[1] CNRS, INSERM, U209, F-69373 Lyon, FRANCE

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1992年 / 98卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：832 / 832

页数：1

共 50 条

[41] DISSOCIATION BETWEEN RENIN-ANGIOTENSIN SYSTEM ACTIVATION AND HEMODYNAMIC DYSFUNCTION INDUCED BY CYCLOSPORINE-A AND CYCLOSPORINE-G IN THE RAT
KASKEL, FJ
CASELLAS, D
MOORE, LC
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 999 - 999
[42] CYCLOSPORINE-A VERSUS CYCLOSPORINE-G - A COMPARATIVE-STUDY OF SURVIVAL, HEPATOTOXICITY, NEPHROTOXICITY, AND SPLENIC ATROPHY IN BALB/C MICE
MASRI, MA
NAIEM, M
PINGLE, S
DAAR, AS
TRANSPLANT INTERNATIONAL, 1988, 1 (01) : 13 - 18
[43] NEW AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF CYCLOSPORINE-A AND CYCLOSPORINE-G IN HUMAN-SERUM
WALLEMACQ, PE
LESNE, M
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 413 : 131 - 140
[44] CYCLOSPORINE-A INHIBITS DIRECTLY INVIVO KERATINOCYTE PROLIFERATION OF LIVING HUMAN-SKIN
URABE, A
KANITAKIS, J
VIAC, J
THIVOLET, J
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (05) : 755 - 757
[45] CYCLOSPORINE-G INHIBITS PROLIFERATION OF A431 CELLS IN A DOSE-DEPENDENT AND TIME-DEPENDENT WAY COMPARABLE TO CYCLOSPORINE-A
TEOFOLI, P
LOTTI, T
BONAN, P
HAUTMANN, G
BELLINI, M
CAMPOLMI, P
CLINICAL RESEARCH, 1993, 41 (02): : A416 - A416
[46] PHARMACOKINETIC PROFILE OF CYCLOSPORINE-A AND CYCLOSPORINE-G AND THEIR EFFECTS ON CELLULAR-IMMUNITY AND GLUCOSE-TOLERANCE IN MALE AND FEMALE WISTAR RATS
FARACI, M
VIGEANT, C
YALE, JF
TRANSPLANTATION, 1988, 45 (03) : 617 - 621
[47] CYCLOSPORINE-G INHIBITS PROLIFERATION OF A431 CELLS IN A DOSE-DEPENDENT AND TIME-DEPENDENT WAY COMPARABLE TO CYCLOSPORINE-A
TEOFOLI, P
LOTTI, T
BONAN, P
HAUTMANN, G
BELLINI, M
CAMPOLMI, P
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (04) : 536 - 536
[48] A MASKED, RANDOMIZED, DOSE-RESPONSE STUDY BETWEEN CYCLOSPORINE-A AND CYCLOSPORINE-G IN THE TREATMENT OF SIGHT-THREATENING UVEITIS OF NONINFECTIOUS ORIGIN
NUSSENBLATT, RB
DESMET, MD
RUBIN, B
FREIDLIN, V
WHITCUP, SM
DAVIS, J
HERMAN, D
BLOOM, JN
SRAN, PK
WHITCHER, S
PALESTINE, A
AUSTIN, H
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1993, 115 (05) : 583 - 591
[49] THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE-A, CYCLOSPORINE-G, AND FK506 ON BONE-MINERAL METABOLISM IN-VIVO
CVETKOVIC, M
MANN, GN
ROMERO, DF
LIANG, XG
MA, YF
JEE, WSS
EPSTEIN, S
TRANSPLANTATION, 1994, 57 (08) : 1231 - 1237
[50] CYCLOSPORINE-H IS A POTENT AND SELECTIVE FORMYL PEPTIDE RECEPTOR ANTAGONIST - COMPARISON WITH N-T-BUTOXYCARBONYL-L-PHENYLALANYL-L-LEUCYL-L-PHENYLALANYL-L-LEUCYL-L-PHENYLALANINE AND CYCLOSPORINE-A, CYCLOSPORINE-B, CYCLOSPORINE-C, CYCLOSPORINE-D, AND CYCLOSPORINE-E
WENZELSEIFERT, K
SEIFERT, R
JOURNAL OF IMMUNOLOGY, 1993, 150 (10): : 4591 - 4599

← 1 2 3 4 5 →